Abstract
We aimed to investigate risk factors of local and distant recurrence in small-sized, node negative breast cancer in women <35 years in a Chinese cohort. Between January 1994 and January 2007, 107 patients with pathologically confirmed small-sized (⩽1 cm), node negative breast cancer who did not receive neoadjuvant or adjuvant chemotherapy were included. The 5-year recurrence-free survival (RFS) was estimated according to different prognostic variables. With a median time of 60 months (range, 8–60 months) follow-up, local and distant recurrence were observed in 25 cases (23.4%). By univariate analysis, HER-2 positivity, triple negative (TN), and high Ki-67 index (⩾14%) were risk factors of a lower RFS (hazard ratio (HR) 6.680, 95% confidence interval (CI) 2.350–18.985, P<0.0001 for HER-2 positive; HR 4.769, 95%CI 1.559–14.591, P=0.006 for TN; HR 6.030, 95%CI 2.659–13.674, P<0.0001 for high Ki-67 index). Patients with grade 3 tumors had a lower RFS (HR 2.922, 95%CI 1.096–7.791, P=0.032) compared with those with grade 1 or grade 2 tumors. By multivariate analysis, HER-2 positivity (HR 10.204, 95%CI 3.391–30.704, P<0.0001), TN (HR 10.521, 95% CI 3.152–35.113, P<0.0001) and high Ki-67 index (HR 10.820, 95%CI 4.338–27.002, P<0.0001) remained risk factors of RFS. In this cohort, HER-2 positivity, triple negative and high Ki-67 index were independent risk factors of RFS in young patients with T1a,bN0 breast cancer. Subsequent pregnancy did not affect RFS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Otto S J, Fracheboud J, Looman C W, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet, 2003, 361: 1411–1417
Berry D A, Cronin K A, Plevritis S K, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 2005, 353: 1784–1792
Duijm L E, Groenewoud J H, Roumen R M, et al. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat, 2007, 106: 113–119
Joensuu H, Pylkkanen L, Toikkanen S. Late mortality from pT1N0M0 breast carcinoma. Cancer, 1999, 85: 2183–2189
Kwon J H, Kim Y J, Lee K W, et al. Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less. BMC Cancer, 2010, 10: 557
Theriault R L, Litton J K, Mittendorf E A, et al. Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer Subtype. Clin Breast Cancer, 2011, 11: 5, 325–331
Ahn S H. Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg, 2004, 139: 27–30
Ahn S H, Son B H, Kim S W, et al. Poor outcome of hormone-receptor positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea—a report from the Korean Breast Cancer Society. J Clin Oncol, 2007, 25: 2360–2368
Rippy E E, Karat I F, Kissin M W. Pregnancy after breast cancer: the importance of active counselling and planning. Breast, 2009, 18: 345–350
Azim H A Jr, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer, 2011, 47: 74–83
Cancer AJ Co AJCC Cancer Staging Manual. New York: Springer, 2002. 6
Voduc K D, Cheang M C, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 2010, 28: 1684–1691
Abahssain H, Lalya I, El M’Rabet F Z, et al. Breast cancer in Moroccan young women: a retrospective study. BMC Res Notes, 2010, 3: 286
Chen A M, Meric-Bernstam F, Hunt K K, et al. Breast conservation after neoadjuvant chemotherapy. Cancer, 2005, 103: 689–695
Gonzalez-Angulo A M, Litton J K, Broglio K R, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol, 2009, 27: 5700–5706
Amar S, McCullough A E, Tan W, et al. Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status. Oncologist, 2010, 15: 1043–1049
Albert J M, Gonzalez-Angulo A M, Guray M, et al. Estrogen/progesterone receptor negativity and HER-2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys, 2010, 77: 1296–1302
Park Y H, Kim S T, Cho E Y, et al. A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or =1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment? Breast Cancer Res Treat, 2010, 119: 653–661
Joensuu H, Isola J, Lundin M, et al. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. Clin Cancer Res, 2003, 9: 923–930
Hanrahan E O, Gonzalez-Angulo A M, Giordano S H, et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol, 2007, 25: 4952–4960
Chia S K, Speers C H, Bryce C J, et al. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol, 2004, 22: 1630–1637
Soerjomataram I, Louwman M W, Ribot J G, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat, 2008, 107: 309–330
Colleoni M, Rotmensz N, Peruzzotti G, et al. Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol, 2004, 15: 1633–1639
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributed equally to this work
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Zhang, X., Li, P., Ma, W. et al. Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population. Sci. China Life Sci. 56, 335–340 (2013). https://doi.org/10.1007/s11427-013-4435-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4435-y